Supporting Homegrown Scale-up
Impact
Paving the Way for Industry Uptake
The BioCanRx translational ecosystem approach accelerates the clinical development of novel immunotherapies using a staged pipeline system.
This has yielded tangible results since projects have advanced from pre-clinical development to clinical evaluation.
Throughout this process, projects have attracted further investment by other partners.
The advancement of a new therapeutic approach towards the clinic has resulted in multiple Knowledge Translation outputs related to commercialization that have and will continue to maximize our long-term impact.
Commercialization not only benefits BioCanRx researchers, but the entire biotechnology industry in Canada as well as the ultimate stakeholder, patients in search of better treatments.
BioCanRx's Translational Approach
Partnerships
Building Partnerships for Better Research
Partners
Stakeholders
Receptors from a variety of sectors along the cancer biotherapeutic translational continuum.
These partnerships help BioCanRx to:
- Enable development of technologies and research design
- Translate project deliverables to relevant receptors
- Mobilize knowledge gained in the conduct of research
- Prepare new technologies for later adoption into the health care system
This multi-faceted view of partner engagement and partnership strategy ensures that BioCanRx is optimally situated to deliver on its overall objectives and outcomes:
- Achieving technological deliverables
- Building a vibrant ecosystem for cancer biotherapeutics development in Canada
- Ensuring delivery and impact of novel therapies in the Canadian health care landscape
Funding Impact
BioCanRx-funded projects have attracted
in partner funds
In addition, BioCanRx researchers have gone on to attract more investments, resulting in spin-out companies.
Ecosystem
Expanding Canada’s Biotechnology Landscape
A number of spin-out companies have been created by BioCanRx researchers who acknowledged BioCanRx funding as a critical support in enabling company creation and/or growth.
Entrepreneurial BioCanRx researchers also note the importance of:
Accessing the network expertise
Using core facilities in advancing their asset development
In the interest of supporting the growth of the Canadian biotechnology space, BioCanRx has partnered with several Canadian biotech firms in support of our funded projects.